JOHNSON & JOHNSON cotiza a 263.73 USD y tiene una capitalización bursátil de $635.6B. En los últimos 12 meses ha facturado $97.9B con un margen de flujo de caja libre del 20.9%. Cotiza a 28.6 veces su flujo de caja libre (P/FCF) y a un PER de 30.2. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-01 |
|---|---|---|---|---|
| Real | — | $2.90 | $2.70 | $2.46 |
| Estimado | $2.53 | $2.85 | $2.68 | $2.46 |
| Sorpresa | — | +1.8% | +0.7% | +0.0% |
| Métrica | JNJ | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 67.9% | 57.0% | +10.8% |
| Operating Margin | — | -38.6% | — |
| Net Margin | 28.5% | -33.6% | +62.0% |
| FCF Margin | 20.9% | -13.9% | +34.8% |
| ROE | 32.9% | -40.4% | +73.3% |
| ROA | 13.5% | -32.0% | +45.5% |
| Current Ratio | 1.03 | 2.84 | -1.81 |
| Debt / Equity | 0.51 | 0.28 | +0.23 |